412 related articles for article (PubMed ID: 19059064)
21. Foundations of opioid risk management.
Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
[TBL] [Abstract][Full Text] [Related]
22. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
23. Chronic opioid therapy in nonmalignant pain.
Portenoy RK
J Pain Symptom Manage; 1990 Feb; 5(1 Suppl):S46-62. PubMed ID: 1969892
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G
Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619
[TBL] [Abstract][Full Text] [Related]
25. Current risk assessment and management paradigms: snapshots in the life of the pain specialist.
Passik SD; Squire P
Pain Med; 2009 Jul; 10 Suppl 2():S101-14. PubMed ID: 19691681
[TBL] [Abstract][Full Text] [Related]
26. Opioid genetics: the key to personalized pain control?
Branford R; Droney J; Ross JR
Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
[TBL] [Abstract][Full Text] [Related]
27. Genetics and variability in opioid response.
Stamer UM; Bayerer B; Stüber F
Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
[TBL] [Abstract][Full Text] [Related]
28. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse.
Passik SD; Kirsh KL
Exp Clin Psychopharmacol; 2008 Oct; 16(5):400-4. PubMed ID: 18837636
[TBL] [Abstract][Full Text] [Related]
29. Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
[TBL] [Abstract][Full Text] [Related]
30. Collaborative practice. Undertreatment of pain and fears of addiction in pediatric chronic pain patients: how do we stop the problem?
Popenhagen MP
J Spec Pediatr Nurs; 2006 Jan; 11(1):61-7. PubMed ID: 16409507
[No Abstract] [Full Text] [Related]
31. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
[TBL] [Abstract][Full Text] [Related]
32. Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
Gibofsky A; Barkin RL
Am J Ther; 2008; 15(3):241-55. PubMed ID: 18496262
[TBL] [Abstract][Full Text] [Related]
33. Pain and genetics.
Fernandez Robles CR; Degnan M; Candiotti KA
Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422
[TBL] [Abstract][Full Text] [Related]
34. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
Hayashida M; Maruyama K
Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
[TBL] [Abstract][Full Text] [Related]
35. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
Zahari Z; Ismail R
Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
[TBL] [Abstract][Full Text] [Related]
36. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics of opioids.
Somogyi AA; Barratt DT; Coller JK
Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
[TBL] [Abstract][Full Text] [Related]
38. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers.
de Leon J; Dinsmore L; Wedlund P
J Clin Psychopharmacol; 2003 Aug; 23(4):420-1. PubMed ID: 12920424
[No Abstract] [Full Text] [Related]
39. Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach.
Escorial M; Muriel J; Agulló L; Zandonai T; Margarit C; Morales D; Peiró AM
Minerva Anestesiol; 2024 May; 90(5):386-396. PubMed ID: 38619184
[TBL] [Abstract][Full Text] [Related]
40. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
